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Abstract Long term follow-up of coronary CT angiog-
raphy (CCTA) is scarce. The aim of the present study was
to assess the prognostic value of CCTA over a follow-up
period of more than 6 years. 218 Patients were included
undergoing 64-slice CCTA. Images were analysed with
regard to the presence of nonobstructive (\50 %) or
obstructive (50 % stenosis) coronary artery disease (CAD).
Major adverse cardiovascular events (MACE) were defined
as death, nonfatal myocardial infarction or urgent coronary
revascularization. CCTA revealed normal coronaries in 49,
nonobstructive lesions in 94, and obstructive CAD in 75
patients. During a median follow-up period of 6.9 years,
MACE occurred in 45 patients (21 %). Annual MACE rates
were 0.3, 2.7, and 6.0 % (p = 0.001), for patients with
normal CCTA, nonobstructive, and obstructive CAD,
respectively. Multivariate Cox regression analysis identi-
fied the number of segments with plaques [hazard ratio
(HR) 1.18, p = 0.002] as well as the presence of obstructive
lesions (HR 2.28, p = 0.036) as independent predictors of
MACE. The present study extends the predictive value of
CCTA over more than 6 years. Patients with normal coro-
nary arteries of CCTA continue to have an excellent cardiac
prognosis, while outcome is progressively worse in patients
with nonobstructive and obstructive CAD.
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Introduction
Coronary CT angiography (CCTA) is widely used for the
noninvasive evaluation of suspected coronary artery disease
(CAD) and can accurately depict nonobstructive or obstruc-
tive coronary lesions. Several single- and multi-center reports
have documented that findings on CCTA are strong and
independent predictors of short-term cardiovascular risk [1]
Specifically, the presence of coronary atheromata, their
number and distribution, the presence of obstructive coronary
stenoses and even their composition have been advocated as
potential predictors for future cardiovascular events [2–5].
The CONFIRM registry has confirmed these results in a large
multicentric and multiethnic population of more than 23,000
patients and a mean follow-up of 2.3 years [6].
However, the majority of published reports had a
somewhat short follow-up (2–3 years) and reports with
longer follow-up are scarce [7, 8]. This is related to the fact
that CCTA is a relatively novel technique which found
wide acceptance with the introduction of the 64-detector
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systems in 2005–2006. However, longer-term follow-up is
imperative if the results from CCTA are to be implemented
in clinical practice and used to guide long-term or even
life-long therapies to reduce cardiovascular risk.
Thus, the aim of the present study was to investigate
whether the prognostic value of CCTA is maintained over a
longer follow-up of more than 6 years and to identify key
imaging findings with an impact on long-term prognosis.
Materials and methods
Patient population and study design
Between January 2005 and July 2007, we included con-
secutive patients undergoing CCTA at the Cardiac Imaging
Center, University Hospital Zurich. The study population
was in part shared with a previously reported registry on
short term outcome prediction by CCTA [2]. Reasons for
referral were typical or atypical chest pain, pathological
exercise test, dyspnea and preoperative cardiac risk eval-
uation. Patients with previous coronary artery bypass
grafting (CABG) were excluded. The need for written
inform consent was waived by the institutional review
board (local ethics committee) because of the purely ret-
rospective nature of the study.
CCTA image acquisition
CCTA image acquistion was performed on a 64-slice CT
system (GE Lightspeed VCT, GE Healthcare, Milwaukee,
WI, or Siemens Somatom Sensation 64, Siemens Medical
Solutions, Forchheim, Germany) as previously published
[2]. In brief, patients underwent unenhanced prospectively
triggered low-dose sequential CT scan of the heart for
coronary artery calcium (CAC) scoring followed by a
contrast-enhanced retrospectively gated spiral CT scan.
Eighty to 135 ml nonionic iodinated contrast material
(Visipaque 320, 320 mg/ml; GE Healthcare, Bucking-
hamshire, UK, or Ultravist 370, 370 mg/ml, Schering AG,
Berlin, Germany) was injected into an antecubital vein
with a flow rate of 5 ml/s followed by a saline chaser bolus.
Pre-scan intravenous beta blocker (metoprolol tartrate,
Lopresor, Daiichi Sankyo, Switzerland) was administrated
if heart rate was above 70 beats/min (bpm) and sublingual
isosorbiddinitrat (Isoket, Schwarz Pharma AG, Munchen-
stein, Switzerland) if there were no contraindications.
ECG-pulsing for radiation dose reduction was used in all
patients. Synchronized to ECG, CT data sets were retro-
spectively reconstructed in mid- to end-diastolic phases
and additional phases if needed for optimal coronary artery
visualization. For post-processing and image interpretation,
the images were then transferred to an external designated
workstation (Advantage Workstation, GE, or Leonardo,
Siemens).
CCTA image interpretation
Axial source images, multiplanar and curved reformations
as well as thin-slab maximum intensity projections were
used for CCTA image interpretation. The coronary arteries
were then subdivided into 17 segments according to a
model proposed by American Heart Association [9]. Ima-
ges were evaluated by consensus of two readers with
experience in cardiac imaging (P. A. K. with 10 years of
experience in cardiac radionuclide imaging and H. A. with
1 year of experience in cardiac CT). Image quality and
interpretability were assessed for each segment. Segments
were defined as nonevaluable if they had severe motion
artifacts and/or severe calcifications obscuring the coronary
lumen. Patients were excluded if one or more proximal
segments or more than three segments overall were none-
valuable. Segments smaller than 1.5 mm diameter were not
included in the analysis.
A coronary plaque was defined as a structure C1 mm2
within and/or adjacent to the coronary artery lumen, which
could be clearly distinguished from the vessel lumen and
the surrounding pericardial/myocardial tissue. The com-
position of plaques was characterized based on the pre-
sence of calcifications as previously reported [2] and
plaques sub-classified into: (1) noncalcified, (2) mixed, and
(3) calcified plaques. The number of coronary segments per
patient with plaques was calculated and given as segment
involvement score (SIS). A coronary plaque was defined as
obstructive if the minimal luminal diameter was less than
50 % of the adjacent reference diameter in either the lon-
gitudinal section or one of the cross-sections [10]. The
number and location of affected segments were recorded
for each patient. Patients without evidence of coronary
plaques on CCTA and without coronary calcium on CACS
scans were considered to have normal coronary arteries.
Coronary artery calcium score (CACS)
Coronary artery lesions were manually planimetered by a
single experienced observer and the total calcium burden in
the coronaries was quantified based on the scoring algo-
rithm of Agatston et al. [11]. The four main arteries were
investigated in all slices and the total calcium burden was
summed to generate the total score.
Follow-up
The following endpoints were recorded: death, nonfatal
myocardial infarction (MI), or late revascularization [with
either percutaneous coronary intervention (PCI) or CABG].
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All revascularization procedures within 90 days of the
CCTA study were excluded from the follow-up analysis, as
they were considered to have been triggered directly by the
CCTA findings. Nonfatal MI was defined according to the
current universal definition of Thygesen et al. [12]. Major
adverse cardiovascular events (MACE) was defined as the
composite endpoint of death, MI, and revascularization.
Statistical analysis
Statistical analysis was performed using the SPSS software
package (SPSS 12.0.1 for Windows, SPSS Corp., Chicago,
IL). Categorical data were expressed in proportions or
percentages and quantitative data were given as
mean ± SD or median and interquartile range (IQR) where
appropriate. Differences between groups were assessed
using the Chi square test for categorical and Mann–Whit-
ney U test or Student’s t test for continuous variables. A
p value\0.05 was considered statistically significant for all
tests. To analyze the follow-up data we obtained cumula-
tive event rates using the Kaplan–Meier function. Event-
free survival curves were plotted for a composite endpoint
of death, MI and coronary revascularization and compared
using the log-rank test. Receiver-operating characteristics
(ROC) analysis was employed to determine the best SIS
cut-off to discriminate the likelihood of MACE. The
optimal cut-off point was determined by using the Youden
index (J value) (calculated as the maximum of
J = SN ? SP - 1, where SN is sensitivity and SP is
specificity, for each cutoff value [13]. Univariate and
multivariate Cox proportional hazard regression models
were applied to identify independent predictors of cardiac
events. Variables were selected in a stepwise forward
selection manner; entry and retention sets with a p \ 0.05
were considered to indicate a significant difference. Vari-
ables included in the models were age, gender, history of
CAD, previous MI, hypertension, hypercholesterolemia,
diabetes mellitus, smoking, CACS, presence of coronary
plaques, presence of coronary stenosis and the SIS. The
regression results are expressed as hazard ratios (HR) and
their respective confidence intervals (CI).
Results
Between January 2005 and July 2007, we enrolled 268
patients who underwent CCTA at our institution. Twenty-
three patients (9 %) had to be excluded due to poor CCTA
image quality. Twenty-seven (10 %) were lost to follow-
up. Thus, 218 patients were included in the analysis.
The mean age of the study population was 62 ± 10 years
and 82 patients were female (38 %). The detailed clinical
characteristics are given in Table 1.
CCTA findings
In 218 patients a total of 3,043 coronary segments were
evaluated. After exclusion of four segments due to insuf-
ficient image quality, plaque burden and composition were
assessed in 3,039 segments. Coronary plaques were found
in 731 segments (24 %). Of these plaques, 30 (4 %) were
non-calcified, 209 (29 %) mixed and 492 (67 %) calcified.
Obstructive lesions were identified in 196 segments (6 %).
The median Agatston score was 90 (range 0–3,968). We
identified 75 patients (34 %) with obstructive CAD, of
which 32 (15 %) had one-vessel, 28 (13 %) two-vessel,
and 15 (7 %) three-vessel disease. Two patients (1 %) had
obstructive left main disease (non-isolated). In 49 patients
(22 %), normal coronary arteries without radiological
evidence for coronary plaques were found. The CT findings
are summarized in Table 2.
Cardiovascular events
During a median follow-up of 6.9 years (IQR
6.3–7.3 years), at least one of the predefined endpoints
occurred in 45 patients (21 %). Overall, we recorded 20
deaths (9 %) and 8 MI (4 %). In 20 patients (9 %) a late
revascularization was performed [CABG (n = 5), PCI
(n = 15)]. Table 3 summarizes the follow-up results in the
study population.
Survival analysis
Figure 1 shows the Kaplan–Meier event-free survival
curves. Patients with normal coronary arteries on CCTA
(e.g., no coronary artery plaques or stenosis present) had an
excellent event-free survival. Only one patient of those
with normal coronary arteries had an event which did not
appear to be cardiac (death from septic shock) (Table 3).
By contrast, prognosis was progressively worse in patients
with non-obstructive and obstructive CAD (Fig. 1).
The highest annual event rate for MACE was noted in
patients with obstructive lesions on CCTA (6.0 %).
Event rates were lower in patients with non-obstructive
CAD (2.7 %), and were very low in patients with normal
coronary arteries (0.3 %) (p \ 0.001) (Fig. 2). The
annual event rate for the composite endpoints death and
MI was 1.9 % for all patients (3.0 % for patients with
obstructive CAD, 1.9 % for patients with non-obstructive
CAD, 0.3 % for patients without CAD respectively,
p = 0.018).
ROC curve analysis yielded a cut-off at C4 coronary
plaques as optimal cut-off providing highest accuracy for
the prediction of MACE on follow-up (area under curve
0.76). Consequently prognosis was worse in patients with a
SIS C 4 compared to patients with SIS \ 4 (Fig. 3).
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Predictors of outcome
The results of univariate Cox regression analysis applied for
clinical characteristics, cardiovascular risk factors and CT
findings are shown in Table 4. Smoking was the only cardio-
vascular risk factor significantly associated with an increased
incidence of cardiac events on follow-up (p = 0.002). Of the
CCTA findings, the presence of coronary plaques (p = 0.009),
the presence of obstructive CAD (p\0.001) and the SIS
(p\0.001) were predictive of a higher event rate. When
multivariate Cox regression analysis was employed, correcting
for baseline clinical characteristics and risk factors, the presence
of coronary stenoses (p = 0.036) and the SIS (p = 0.002)
emerged as the only independent predictors of MACE.
Table 1 Clinical characteristics
of the study population
Data not shown as n (%) are
mean ± SD
ACEI angiotensin converting
enzyme inhibitor, ARB
angiotensin receptor blockers,
CAD coronary artery disease,
CABG coronary artery bypass
grafting, MI myocardial
infarction, PCI percutaneous
coronary intervention
All patients
(n = 218)
Patients with events
(n = 45)
Patients without events
(n = 173)
p
Age (years) 62 ± 10 65 ± 11 61 ± 10 0.06
Female gender [n (%)] 82 (38 %) 13 (29 %) 69 (40 %) 0.18
BMI (kg/m2) 27 ± 4 27 ± 4 27 ± 4 0.93
Cardiovascular risk factor [n (%)]
Obesity 43 (20 %) 7 (16 %) 36 (21 %) 0.43
Diabetes mellitus 31 (14 %) 10 (22 %) 21 (12 %) 0.08
Hypercholesterolemia 98 (45 %) 23 (51 %) 75 (43 %) 0.35
Arterial hypertension 128 (59 %) 26 (58 %) 102 (59 %) 0.88
Family history of
CAD
56 (26 %) 14 (31 %) 42 (24 %) 0.35
Current smoking 79 (36 %) 25 (56 %) 54 (31 %) 0.003
Current medication [n (%)]
ACEI/ARB 83 (38 %) 21 (47 %) 62 (36 %) 0.18
Nitrates 17 (8 %) 4 (9 %) 13 (8 %) 0.76
Beta-receptor
antagonists
87 (40 %) 19 (42 %) 68 (39 %) 0.72
Aspirin 121 (56 %) 26 (58 %) 95 (55 %) 0.73
Statins 73 (33 %) 13 (29 %) 60 (35 %) 0.46
Cardiac history [n (%)]
Known CAD 31 (14 %) 12 (27 %) 19 (11 %) 0.007
Previous MI 17 (8 %) 7 (16 %) 10 (6 %) 0.03
Previous PCI 28 (13 %) 8 (18 %) 20 (12 %) 0.27
Table 2 CT-findings
Data not shown as n (%) are
mean ± SD
CTA computed tomography
angiography, CAD coronary
artery disease
a Calcium score is given as
Agatston score as median and
interquartile range
All patients
(n = 218)
Patients with events
(n = 45)
Patients without events
(n = 173)
p
Total calcium scorea 90 (0–490) 478 (204–1,212) 34 (0–356) \0.001
Coronary plaques n in CTA
No plaques, CTA
normal
49 (22 %) 1 (2 %) 48 (28 %) \0.001
Segment
involvement score
3.4 ± 3.1 5.5 ± 3.0 2.8 ± 2.9 \0.001
Nonobstructive
plaques only
94 (43 %) 15 (33 %) 79 (46 %) 0.14
Obstructive plaques 75 (34 %) 29 (64 %) 46 (27 %) \0.001
Left-main disease 2 (1 %) 1 (2 %) 1 (1 %) 0.30
One-vessel disease 32 (15 %) 11 (24 %) 21 (12 %) 0.04
Two-vessel disease 28 (13 %) 13 (29 %) 15 (9 %) \0.001
Three-vessel
disease
15 (7 %) 5 (11 %) 10 (6 %) 0.21
Left dominance 20 (9 %) 2 (4 %) 18 (10 %) 0.22
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Discussion
The present study expands the prognostic value of CCTA
over a long follow-up period of more than 6 years, and
thereby builds on existing prospective CCTA studies with
shorter follow-up. In particular, it documents an excellent
long-term prognosis of normal (plaque-free) coronary
arteries on CCTA with a very low likelihood for cardiac
events on follow-up. Indeed, there was only one death in
the group of patients with normal coronary arteries on
CCTA, which was most probably unrelated to a cardiac
etiology (septic shock). However, the prognosis was pro-
gressively worse in patients with non-obstructive and
obstructive CAD with cardiac event rates (death/MI) of 1.9
and 3.0 %, respectively. In a multivariate Cox regression
model, corrected for several baseline clinical characteris-
tics and cardiovascular risk factors (including age, gender,
history of CAD, diabetes, hypertension and others) the only
significant independent predictors of MACE were the
number of coronary segments affected by atherosclerotic
plaques and the presence of obstructive CAD on CCTA.
To our knowledge, this is the longest follow-up so far
obtained in a cohort of patients undergoing state-of-the art
64-slice CCTA. Slightly longer follow-up (78 months) has
been obtained with electron-beam CT (EBCT) [14]. Ostrom
and colleagues demonstrated comparably low event rates for
patients with normal coronary arteries on EBCT, and a
progressive increase in event rates with non-obstructive and
obstructive CAD. However, EBCT offers limited spatial
resolution compared to CCTA. With state-of-the-art 64-slice
CCTA or higher-end devices, isotropic sub-millimeter spa-
tial resolution is easily achieved, which improves the
detection of smaller, particularly non-calcified plaques. Our
very low event rate of 0.3 %/year in patients with com-
pletely normal coronary arteries confirms the results of the
recent large CONFIRM registry [6], which showed a com-
parably low event rate, and extends these results over a
longer period of time. Our results are in line with a recent
publication by Andreini et al. [7] who followed 1,304
patients for more than 4 years and reported a similar pro-
gressive increase in event rates for patients with non-
obstructive and obstructive CAD. Sozzi et al. reported a
slightly lower MACE rate compared to our results during a
follow-up of 5 years. MACE rates were 0, 1.2 and 4.2 % for
patients with normal coronary arteries, non-obstructive and
obstructive CAD respectively, albeit excluding death as an
endpoint [8].
Hadamitzsky et al. followed 1,584 patients for 5.6 years
and found slightly lower annual death/MI rates at 0.2, 1.1
and 1.5 % for normal coronaries, non-obstructive and
obstructive CAD, respectively. However in this report,
patients were on average 4 years younger, had lower
prevalence of diabetes and lower overall calcium scores
compared to our study population [15]. In the CASS reg-
istry, 7-year death-rates in 3,136 patients with normal
coronary arteries at invasive angiography was 4 %, hence
slightly higher compared to the 0.3 % death rate for a
normal CCTA. This indicates that a ‘‘normal’’ invasive
angiogram may overlook the presence of non-stenotic
eccentric plaque, with potential impact on patient
prognosis.
Among patients with non-obstructive CAD on CCTA,
we observed a low event rate during the first 3 years of
follow-up (only slightly higher than among patients with
normal coronary arteries). However, in contrast to the prior
publication by Andreini et al. event rates increased sig-
nificantly in the second period of observation (the second
3 years). As a result, separation of survival curves for the
group with normal coronary arteries and the group with
non-obstructive CAD occurred only after approximately
3 years. This suggests that the lack of obstructive CAD on
CCTA may provide a ‘‘warranty period’’ of approximately
3 years during which event rates are rather low. This is in
keeping with a recent hybrid SPECT (single photon
Table 3 Follow-up results
All Patients
(n = 218)
Patients with
obstructive
CAD (n = 75)
Patients with
non-obstructive
CAD (n = 94)
Patients without
CAD (n = 49)
p
MACE [n (%)] 45 (21 %) 29 (39 %) 15 (16 %) 1 (2 %) \0.001
All-cause mortality 20 (9 %) 9 (12 %) 10 (11 %) 1 (2 %) 0.14
Myocardial infarction 8 (4 %) 6 (8 %) 2 (2 %) 0 (0 %) 0.04
Revascularizationa 20 (9 %) 15 (20 %) 5 (5 %) 0 (0 %) \0.001
CABG 5 (2 %) 4 (5 %) 1 (1 %) 0 (0 %) 0.09
PCI 15 (7 %) 11 (15 %) 4 (4 %) 0 (0 %) 0.0028
Values are depicted in n (%)
MACE major cardiac event (myocardial infarction, death, revascularization), CABG coronary artery bypass grafting, PCI percutaneous coronary
intervention
a Revascularization within 3 months of the CT Scan were not included
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emission computed tomography)/CT study by Chang and
colleagues, which assessed the incremental prognostic
value of coronary artery calcium score (CACS) over
myocardial perfusion in 1,126 subjects with normal SPECT
scans [16]. There was a 2.8-fold relative increase for death/
MI when the CACS was severe ([400) versus minimal
(B10) despite normal SPECT scans. Interestingly, separa-
tion of the survival curves occurred at 3–5 years. When
integrated with our findings, this indicates, that if coronary
atherosclerosis (by either CACS or CCTA) is severe, the
‘‘warranty period’’ of lacking obstructive coronary stenoses
expires after 3–5 years. This is clinically important, as
patients and physicians are often falsely reassured by the
lack of obstructive CAD. However, the presence of plaques
should be strongly considered when counseling the patient
about medical or life-style interventions to reduce cardio-
vascular risk. These interventions are generally intended as
life-long therapies and thereby may have a significant
benefit on long-term follow-up.
Limitations
Several methodological limitations of the present manu-
script should be acknowledged, including the single-center
design and the limited number of patients. Any preliminary
Fig. 1 Kaplan–Meier analysis for event-free survival of death/
myocardial infarction (a) or death/myocardial infarction/revascular-
ization (b) in patients with normal coronaries, non-obstructive and
obstructive coronary lesions on CT angiography
Fig. 2 Annual event rates for patients with normal coronaries, non-
obstructive coronary artery disease (CAD), and obstructive CAD
Fig. 3 Kaplan–Meier analysis for event-free survival in patients with
segment involvement score C4 and \4
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conclusion drawn from the present data awaits confirma-
tion in forthcoming larger multicentric and multinational
CT registries.
This small sample size is related to the fact that we
included the first patients to be scanned in our department
with a 64-slice CT scanner starting in 2005 to obtain the
longest follow-up possible. The limited sample size pre-
cluded to perform extensive multivariate Cox proportional
hazards models to assess the independent predictive value of
vessel distribution pattern or coronary plaque composition
on long-term prognosis. CCTA was performed using spiral
acquisition with retrospective ECG-gating. Although ECG-
modulation of the tube current was performed, this protocol
is associated with a significantly higher radiation exposure
compared to the currently recommended prospectively
triggered step-and-shoot protocols [17]. However, the spiral
protocol was the standard clinical protocol used in our center
prior to 2007–2008. The drop-out rate of 50 patients (19 %)
due to insufficient CCTA image quality and loss of follow up
is considerably high. This may be related to the initial
learning curve with 64-slice CT in the early phase of the
study and the long-follow-up, respectively. The current use
of clinical CCTA is focused on patients with low pre-test
probability, as the strength at CCTA is the high negative
predictive value. In the early years, CCTA was applied even
in higher pre-test likelihood populations explaining the rel-
atively high CAD prevalence in the study population.
Conclusion
Patients with normal coronary arteries on CCTA have an
excellent prognosis on long-term follow-up of more than
6 years, while outcome is progressively worse in patients
with nonobstructive and obstructive CAD. The present
study extends the proven predictive value of CCTA in
short-term follow-up studies over a longer observation term
of more than 6 years.
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